High-density lipoprotein cholesterol-raising strategies

被引:14
|
作者
Kuvin, JT [1 ]
Alsheikh-Ali, AA [1 ]
Karas, RH [1 ]
机构
[1] Tufts Univ, Sch Med, New England Med Ctr, Dept Med,Div Cardiol, Boston, MA 02111 USA
关键词
apolipoprotein; cholesterol; coronary artery disease; HDL;
D O I
10.1097/01.fjc.0000199684.20578.7c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a distinct inverse relationship between high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease risk. HDL-C mediates cholesterol efflux from the vasculature and promotes anti-oxidant, anti-inflammatory, and anti-thrornbotic effects. There are multiple lifestyle and therapeutic interventions that raise HDL-C, and there is increasing evidence that these interventions improve cardiovascular outcomes. Recent findings regarding the role of HDL-C in cholesterol metabolism offer new strategies designed to target atherosclerosis. This review highlights the utility of existing HDL-C-raising strategies and examines new potential therapies.
引用
收藏
页码:196 / 204
页数:9
相关论文
共 50 条
  • [31] Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment
    Kolovou, GD
    Cokkinos, DV
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (05) : 265 - 268
  • [32] High-Density Lipoprotein Cholesterol and Mortality: Too Much of a Good Thing?
    Hamer, Mark
    O'Donovan, Gary
    Stamatakis, Emmanuel
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (03) : 669 - 672
  • [33] Potential therapeutic agents that raise high-density lipoprotein cholesterol levels
    Rodriguez, A
    Doshi, RR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (02) : 167 - 175
  • [34] Association of ratios of monocyte/high-density lipoprotein cholesterol and neutrophil/high-density lipoprotein cholesterol with atherosclerotic plaque type on coronary computed tomography
    Okan, Taha
    Topaloglu, Caner
    CARDIOVASCULAR JOURNAL OF AFRICA, 2024,
  • [35] Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality
    Barylski, Marcin
    Toth, Peter P.
    Nikolic, Dragana
    Banach, Maciej
    Rizzo, Manfredi
    Montalto, Giuseppe
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 28 (03) : 453 - 461
  • [36] Association of the remnant cholesterol to high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients
    Wang, Zebin
    Huang, Sibing
    Tian, Na
    Xu, Qingdong
    Zhan, Xiaojiang
    Peng, Fenfen
    Wang, Xiaoyang
    Su, Ning
    Feng, Xiaoran
    Tang, Xingming
    Wu, Xianfeng
    Zhou, Qian
    Liang, Jianbo
    Li, Jiao
    Wen, Yueqiang
    LIPIDS IN HEALTH AND DISEASE, 2025, 24 (01)
  • [37] High HDL (High-Density Lipoprotein) Cholesterol Increases Cardiovascular Risk in Hypertensive Patients
    Trimarco, Valentina
    Izzo, Raffaele
    Morisco, Carmine
    Mone, Pasquale
    Virginia Manzi, Maria
    Falco, Angela
    Pacella, Daniela
    Gallo, Paola
    Lembo, Maria
    Santulli, Gaetano
    Trimarco, Bruno
    HYPERTENSION, 2022, 79 (10) : 2355 - 2363
  • [38] Assembly of high-density lipoprotein
    Yokoyama, S
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (01) : 20 - 27
  • [39] Significant Increase in High-Density Lipoprotein Cholesterol with Fibrates Is Associated with Low Pretreatment High-Density Lipoprotein Cholesterol: Findings from an Outpatient Clinic Setting
    Ramachandran, Sud
    Abbas, Ahmed
    Saraf, Sanjay
    Raju, Jessie
    Jewkes, Christina
    Jones, Alan F.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2012, 10 (03) : 189 - 194
  • [40] Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol
    Juren, Andrew J.
    Sarwal, Gautamn
    Al-Sarraf, Ahmad
    Vrablik, Michal
    Chan, Darren
    Humphries, Karin H.
    Frohlich, Jiri J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (03) : 194 - 198